Your browser doesn't support javascript.
loading
High prevalence of SARS-CoV-2 antibodies and low prevalence of SARS-CoV-2 RNA in cats recently exposed to human cases.
Daigle, Laurence; Khalid, Hattaw; Gagnon, Carl A; Arsenault, Julie; Bienzle, Dorothee; Bisson, Sarah-Kim; Blais, Marie-Claude; Denis-Robichaud, José; Forest, Caroline; Grenier St-Sauveur, Valérie; Koszegi, Marika; MacNicol, Jennifer; Nantel-Fortier, Nicolas; Nury, Charlotte; Prystajecky, Natalie; Fraser, Erin; Carabin, Hélène; Aenishaenslin, Cécile.
Afiliação
  • Daigle L; Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada. laurence.daigle.1@umontreal.ca.
  • Khalid H; Groupe de recherche en épidémiologie des zoonoses et santé publique (GREZOSP), Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada. laurence.daigle.1@umontreal.ca.
  • Gagnon CA; Centre de recherche en santé publique de l'Université de Montréal et du CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montréal, Qc, Canada. laurence.daigle.1@umontreal.ca.
  • Arsenault J; BC Centre for Disease Control, Vancouver, BC, Canada.
  • Bienzle D; School of Population and Public Health, UBC Centre for Disease Control, University of British Columbia, Vancouver, BC, Canada.
  • Bisson SK; Swine and Poultry Infectious Diseases Research Center - FRQ, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • Blais MC; Molecular Diagnostic Laboratory (MDL), Centre de Diagnostic Vétérinaire de l'Université de Montréal (CDVUM), Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • Denis-Robichaud J; Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • Forest C; Groupe de recherche en épidémiologie des zoonoses et santé publique (GREZOSP), Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • Grenier St-Sauveur V; Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
  • Koszegi M; Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • MacNicol J; Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • Nantel-Fortier N; Groupe de recherche en épidémiologie des zoonoses et santé publique (GREZOSP), Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • Nury C; Independent Researcher, Amqui, QC, Canada.
  • Prystajecky N; Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • Fraser E; Molecular Diagnostic Laboratory (MDL), Centre de Diagnostic Vétérinaire de l'Université de Montréal (CDVUM), Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • Carabin H; Molecular Diagnostic Laboratory (MDL), Centre de Diagnostic Vétérinaire de l'Université de Montréal (CDVUM), Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Qc, Canada.
  • Aenishaenslin C; Department of Pathobiology, University of Guelph, Guelph, ON, Canada.
BMC Vet Res ; 20(1): 304, 2024 Jul 09.
Article em En | MEDLINE | ID: mdl-38982461
ABSTRACT

BACKGROUND:

The primary objective of this cross-sectional study, conducted in Québec and Bristish Columbia (Canada) between February 2021 and January 2022, was to measure the prevalence of viral RNA in oronasal and rectal swabs and serum antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) amongst cats living in households with at least one confirmed human case. Secondary objectives included a description of potential risk factors for the presence of SARS-CoV-2 antibodies and an estimation of the association between the presence of viral RNA in swabs as well as SARS-CoV-2 antibodies and clinical signs. Oronasal and rectal swabs and sera were collected from 55 cats from 40 households at most 15 days after a human case confirmation, and at up to two follow-up visits. A RT-qPCR assay and an ELISA were used to detect SARS-CoV-2 RNA in swabs and serum SARS-CoV-2 IgG antibodies, respectively. Prevalence and 95% Bayesian credibility intervals (BCI) were calculated, and associations were evaluated using prevalence ratio and 95% BCI obtained from Bayesian mixed log-binomial models.

RESULTS:

Nine (0.16; 95% BCI = 0.08-0.28) and 38 (0.69; 95% BCI = 0.56-0.80) cats had at least one positive RT-qPCR and at least one positive serological test result, respectively. No risk factor was associated with the prevalence of SARS-CoV-2 serum antibodies. The prevalence of clinical signs suggestive of COVID-19 in cats, mainly sneezing, was 2.12 (95% BCI = 1.03-3.98) times higher amongst cats with detectable viral RNA compared to those without.

CONCLUSIONS:

We showed that cats develop antibodies to SARS-CoV-2 when exposed to recent human cases, but detection of viral RNA on swabs is rare, even when sampling occurs soon after confirmation of a human case. Moreover, cats with detectable levels of virus showed clinical signs more often than cats without signs, which can be useful for the management of such cases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Viral / Doenças do Gato / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Viral / Doenças do Gato / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2024 Tipo de documento: Article